Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Fengle Seed Co., Ltd. is a leading Chinese agricultural biotechnology company that specializes in the research, development, and commercialization of crop seeds and plant-based chemical products. As the first listed company in the Chinese seed industry, it operates a significant R&D platform focused on molecular breeding and genetic improvement for crops such as corn, rice, and melons. The company also maintains a dominant position in the healthcare sector through its subsidiary, Fengle Perfume, which is one of the world's largest producers of natural menthol and peppermint oil for pharmaceutical applications. Its products are essential components in various over-the-counter medications, topical analgesics, and oral care products. Fengle's business model integrates advanced life science research with large-scale manufacturing to serve global agricultural and healthcare markets. The company is headquartered in Hefei, Anhui Province, and is recognized as a key national enterprise in agricultural industrialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fengle.